academic article

• Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. 2016
• SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer..  Breast cancer research and treatment.  130:123-131.